Biomarkers and Receptor Targeted Therapies Reduce Clinical Trial Risk in Non–Small-Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Biomarkers and Receptor Targeted Therapies Reduce Clinical Trial Risk in Non–Small-Cell Lung Cancer

DOI Full Paper Access

49

Citations

8

References

2014

Year

Adam Falconi, Gilberto Lopes, Jayson L. Parker

Journal of Thoracic Oncology

Non–small-cell Lung CancerPrognostic BiomarkersMedicineBiomarker TargetImmunologyClinical TrialsOncologyRadiation OncologyLung CancerHealth Sciences

References

	Year	Citations

Page 1